The Autoimmune Disease Diagnostics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
New York, NY -- (SBWIRE) -- 03/24/2017 -- Autoimmune Disease Diagnostics Market: Drivers and Challenges
The global autoimmune disease diagnostics market expected to witness robust growth owning to increased prevalence of autoimmune disease. According to the American Autoimmune Related Diseases Association (AARDA), 50 million Americans are living with autoimmune disease. Discoveries in diagnostic techniques in autoimmune disease, increasing public awareness for autoimmune disorders, upgraded laboratory techniques and automation are the major driving factors for the market growth. The novel technologies such as portable devices and novel biomarkers are anticipated to drive market growth. The key restraints for this market include intense competitive pricing among manufacturers, growing demand for innovative technological products and unavailability of skilled manpower are hampering the autoimmune disease diagnostics market.
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/3412
Global autoimmune disease diagnostics market is expected to show significant growth due to the mergers & acquisition between the companies and research institutes. Moreover, with the introduction of new technologies and services in the given market which is expected to increase point of care (POC) tests which may change the market dynamics over a given period of forecast. Based on the disease type, segments such as systemic autoimmune diagnostics in global autoimmune disease diagnostics market is expected to grow positively owing to increasing occurrences of these diseases.
Autoimmune Disease Diagnostics Market: Regional Overview
Geographically, global autoimmune disease diagnostics market is classified into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is demonstrating increased incidence of autoimmune disorder because of change in lifestyle, unhealthy eating and hygiene. NIH estimates up to 23.5 million Americans have an autoimmune disease. In comparison, cancer affects up to 9 million and heart disease up to 22 million. Furthermore, availability of vast unexploited opportunities in the growing European countries is expected to strengthen growth over the forecasted period. Despite of having lower prevalence and incidence rate, market size of Asia pacific is considerable because of its sizable population.
Autoimmune Disease Diagnostics Market: Key Players
To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/3412
Some of the major players in the global Autoimmune Disease Diagnostics Market include Bio-Rad, Siemens Healthcare, Roche Diagnostics SQI Diagnostics, Abbott Laboratories, AESKU Diagnostics, Beckman Coulter Inc., INOVA Diagnostics Inc., BioMerieux SA, Crescendo Bioscience, and Hemagen Diagnostics, Quest Diagnostics.